Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment planning and sales; and medical equipment leasing activities. The company was founded in 2009 and is headquartered in New Taipei City, Taiwan.
Frequently asked questions
What sector does Concord Medical Co., Ltd. (6518) operate in?
Concord Medical Co., Ltd. belongs to the Other sector and operates in the Medical Instruments & Supplies industry.
What is Concord Medical Co., Ltd. (6518) current stock price?
As of the latest data, Concord Medical Co., Ltd. stock price is NT$30.25, with a previous close of NT$31.55. Concord Medical Co., Ltd. lost -NT$1.30 in the last trading session, representing a -4.12% loss.
What is Concord Medical Co., Ltd. (6518) current market capitalization?
Concord Medical Co., Ltd. market cap is approximately 1.01 billion.
What is Concord Medical Co., Ltd. (6518) Earnings Per Share (EPS)?
The trailing EPS is NT$2.01.
What is Concord Medical Co., Ltd. (6518) Price-to-Earnings (P/E) ratio?
Concord Medical Co., Ltd. current P/E ratio is 15.05.
Does Concord Medical Co., Ltd. (6518) pay dividends?
Yes. Concord Medical Co., Ltd. pays annual dividends with an annualized yield of 4.96% and an estimated annual payout of NT$1.50 per share.
When is the next ex-dividend date for Concord Medical Co., Ltd. (6518)?
The next ex-dividend date is scheduled for April 10, 2027.
What is Concord Medical Co., Ltd. (6518) beta (volatility) score?
Concord Medical Co., Ltd. has a beta of 0.333, indicating lower volatility than the overall market.
